The quality of marine bathing water is currently assessed by monitoring the levels of faecal indicator bacteria. Among other drawbacks, results are retrospective using the traditional culture based methods. A rapid method is thus needed as an early warning to bathers for bacterial contamination in marine bathing waters. Total lipopolysaccharide (LPS) was chosen here as a potential general biomarker for bacterial contamination. Levels of total LPS, measured using a Kinetic QCL™ Limulus Amebocyte Lysate (LAL) assay, highly correlated with enumerated Escherichia coli and Bacteroides species. Levels of LPS in excess of 50 EU mL-1 were found to equate with water that was unsuitable for bathing under the current European Union regulations. Results showed that monitoring the levels of total LPS has a potential applicability as a rapid method for screening the quality of marine bathing water. More importantly, the LAL assay overcome the retrospective results when using culture based assessment since the LAL assay takes less than 30 minutes. Although false positive events were not detected, the occurrence of a false positive has been hypothesised, hence a more specific faecal biomarker was also investigated. LPS of five Bacteroides species (B. fragilis, B. caccae, B. ovatus, B. xylanisolvens and B. finegoldii) isolated from marine bathing waters samples were successfully profiled and showed high similarity between isolates in LPS gel electrophoresis banding pattern. Similar results were shown when investigating the endotoxic activity of Bacteroides species with the Kinetic QCL™ LAL assay. The potential biological relevance of Bacteroides LPS was also investigated in cell culture models indicating that Bacteroides showed similar induction of proinflammatory cytokines (TNF-α, IL-6 and IL-1α) and generally the biological activity was approximately 100 fold less than E. coli LPS. In addition, an ELISA assay was designed for the detection of Bacteroides LPS. Results showed that the Bacteroides LPS has a high potential to be used as a faecal biomarker, however, further work is required to develop a fully functional assay. The potential biological relevance of LPS present in contaminated bathing waters was also investigated in cell culture models. Results showed that there is a significant difference in the production of proinflammatory cytokines in comparison to “clean” bathing waters. Thus, results suggest that the European Directive regulations should be extended to cover the levels of total LPS in bathing waters to assure safety to the users of marine recreational water.

Le fer est un oligo-élément nécessaire pour le fonctionnement normal de toutes les cellules de l'organisme et joue un rôle essentiel dans de nombreuses fonctions biologiques. Cependant, le niveau de fer dans le corps doit être bien réglé, sinon la carence en fer entraine des divers états pathologiques tels que l'anémie et la diminution de l’immunité. D'autre part, une surcharge en fer potentialise la multiplication des germes, aggrave l’infection et la formation de radicaux libres ayant des effets toxiques sur les cellules et leurs composants, ce qui favorise les maladies cardio-vasculaires, l'inflammation et le cancer. L'hepcidine (HAMP), un régulateur négatif de l'absorption du fer, induit la dégradation de la ferroportine (FPN), le seul exportateur connu de fer ce qui réduit sa libération par les macrophages et inhibe son absorption gastro-intestinale. HAMP est synthétisé principalement par les hépatocytes, mais aussi par les macrophages. Cependant, il y a très peu de données sur la façon dont HAMP est régulé au niveau des macrophages. Plus récemment, nous avons constaté que l’induction de l’hepcidin dans le foie par le polysaccharide (LPS) est dépendante de la voie de signalisation médiée par « Toll-like receptor 4 » (TLR4). Grâce au TLR4, le LPS induit l'activation des macrophages qui sécrètent de nombreuses différentes cytokines inflammatoires, y compris Interleukine 6 (IL-6), responsable de l'expression de HAMP hépatique. Dans le premier chapitre de la présente étude, nous avons étudié la régulation de HAMP dans la lignée cellulaire macrophagique RAW264.7 et dans les macrophages péritonéaux murins stimulés par différents ligands des TLRs. Nous avons constaté que TLR2 et TLR4 par l'intermédiaire de la protéine adaptatrice « myeloid differentiation primary response gene 88 » (MyD88) activent l'expression de HAMP dans les cellules RAW264.7 et les macrophages péritonéaux sauvages murins, tandis que cette expression a été supprimée dans les macrophages isolés des souris TLR2-/-, TLR4-déficiente ou MyD88-/-. En outre, nous avons constaté que la production d'IL-6 par les cellules RAW264.7 stimulées avec du LPS a été renforcée par l’ajout des quantités élevées de fer dans le milieu de culture. Au cours de l’inflammation, le niveau de HAMP est fortement augmenté. Ainsi, lorsque l'inflammation persiste, l’expression de HAMP continue à être activée par des cytokines pro-inflammatoires conduisant à une hyposidérémie. Malgré que cette dernière soit considérée comme une défense de l'hôte pour priver les micro-organismes de fer, celle ci cause un développement d'anémies nommées anémies des maladies chroniques. Ainsi, dans le deuxième chapitre de la présente étude, nous avons étudié l'implication des TLRs et leurs protéines adaptatrices MyD88 et TIR-domain-containing adapter-inducing interferon-β (TRIF) dans le développement des hyposidérémies. En utilisant des souris déficientes en MyD88 et TRIF, nous avons montré que les voies de signalisations MyD88 et TRIF sont essentielles pour l’induction de HAMP par le LPS. Malgré l'absence de HAMP, les souris déficientes ont été capables de développer une hyposidérémie, mais la réponse des souris déficientes en MyD88 a été très légère, ce qui indique l'exigence de cette protéine pour assurer une réponse maximale au LPS. En outre, nous avons constaté que la signalisation MyD88 est nécessaire pour le stockage du fer au niveau de la rate, ainsi que l'induction de lipocaline 2 (LCN2), qui est une protéine impliquée dans la fixation du fer pour limiter la croissance bactérienne. Indépendamment de MyD88 ou TRIF, l'activation de TLR4 et TLR3 a conduit, au niveau de la rate, à une diminution rapide de l’expression de FPN et du « Human hemochromatosis protein » (HFE) qui est une protéine qui limite la séquestration du fer cellulaire à partir de la circulation. Cependant, malgré cette baisse d’expression, le manque de la signalisation MyD88 a altéré de manière significative la réponse hyposidérémique. En établissant le rôle des TLRs et de la protéine adaptatrice MyD88 dans la diminution du taux du fer sérique au cours de la réponse inflammatoire, nous avons remarqué qu’en réponse au surcharge en fer les souris déficientes en MyD88 accumulent de manière significative plus de fer hépatique par rapport aux souris sauvages, et cela indépendamment des TLRs. Ainsi, dans le troisième chapitre de la présente étude, nous avons étudié le phénotype observé chez les souris déficientes en MyD88. Nous avons trouvé que l'expression de HAMP chez ces souris a été plus faible que celle des souris de type sauvage. Pour cela, nous avons exploré la signalisation à travers la voie du « Bone Morphogenetic Proteins 6 » (BMP6) qui est considérée comme étant la voie fondamentale de la régulation de HAMP en réponse aux concentrations du fer intracellulaires et extracellulaires et nous avons trouvé que l'expression protéique de Smad4, un régulateur positif de l'expression de HAMP, est significativement plus faible chez les souris MyD88-/- par rapport aux souris sauvages. En outre, on a montré que MyD88 interagit avec « mothers against decapentaplegic, Drosophila, homolog 4 » (Smad4) et que cette interaction est essentielle pour l’induction de HAMP à travers la voie BMP6. En conclusion, notre étude montre que l'expression de HAMP dans les macrophages est régulée principalement par TLR2 et TLR4 à travers la voie MyD88 et que l'accumulation du fer dans les macrophages peut affecter les niveaux des cytokines pro-inflammatoires. En outre, nos analyses démontrent que le développement d’hyposidérémie en réponse au LPS se produit par l'intermédiaire d’un mécanisme dépendant de MyD88 qui est dissociée de la production de cytokines et de HAMP. En plus, nos recherches montrent que MyD88 est nécessaire pour l'expression de Smad4 et cela pour garantir une réponse optimale à travers la signalisation BMP6, conduisant ainsi à une expression adéquate de HAMP. Enfin, la protéine MyD88 joue un rôle crucial dans, la régulation de HAMP au niveau des macrophages, la diminution du taux du fer sérique en réponse au LPS et le maintien de l'homéostasie du fer. / Iron is an oligoelement necessary for normal functioning of all body cells and plays an essential role in many biological functions. However, the level of iron in the body must be well regulated, otherwise iron deficiency results in various pathological conditions such as anemia and decreased immunity. On the other hand, iron overload potentiates the multiplication of germs and infection worsens, and the formation of free radicals with toxic effects on cells and their components, thus promoting cardiovascular diseases, inflammation and cancer. Hepcidin (HAMP), a negative regulator of iron absorption, induces the degradation of the only known iron exporter ferroportin (FPN) resulting in the reduction of iron release by macrophages and in the inhibition of its gastrointestinal uptake. HAMP is synthesized mainly by hepatocytes but also by macrophages. However, there are very little data about how HAMP is regulated in macrophages. More recently, we found that HAMP induction in the liver by polysaccharide (LPS) is dependent on the signaling pathway mediated by Toll-like receptor 4 (TLR4). Through TLR4, LPS induces the activation of macrophages which will secrete many different inflammatory cytokines, including Interleukine 6 (IL-6), responsible of hepatic HAMP expression. In the first chapter of the present study, we investigated HAMP regulation in the RAW264.7 macrophage cell line and in murine peritoneal macrophages stimulated with different TLR ligands. We found that TLR2 and TLR4 signaling through the myeloid differentiation primary response gene 88 (MyD88) adaptor protein activate hepcidin expression in RAW264.7 cells and in wild-type murine peritoneal macrophages, while this expression was abolished in TLR2−/−, TLR4-deficient or MyD88−/− isolated macrophages. Moreover, we found that IL-6 production by RAW264.7 cells stimulated with LPS was enhanced by high amounts of iron present in the culture medium. During inflammation, the level of HAMP is greatly increased. Thus, when inflammation persists, HAMP expression continues to be activated by proinflammatory cytokines leading to hypoferremia. Despite that the latter is considered as host defence to deprive microorganisms of iron, this will cause the development of anemia of chronic disease. Thus, in the second chapter of the present study, we investigated the involvement of TLRs signaling through their adaptor proteins MyD88 and TIR-domain-containing adapter-inducing interferon-β (TRIF) in the development of hypoferremia. Using MyD88-deficient and TRIF-deficient mice, we show that MyD88 and TRIF signaling pathways are critical for HAMP up-regulation by LPS. Despite the lack of HAMP, both deficient mice were able to develop hypoferremia; however the response in MyD88 deficient mice was very mild, indicating the requirement of MyD88 adaptor protein for the acute hypoferremic response to LPS. Furthermore, we found that MyD88 signaling is required for iron sequestration in the spleen and the induction of lipocalin 2 (LCN2) which is a protein involved in iron sequestration that in turn limits bacterial growth. Independently of MyD88 or TRIF, the activation of TLR4 and TLR3 signaling resulted in rapid down-regulation of splenic FPN and the Human hemochromatosis protein (HFE) which is a protein that limit cellular iron uptake from the circulation. However, despite the latter down-regulation, the lack of MyD88 signaling significantly impaired the hypoferremic response. While establishing the role of TLRs signaling through MyD88 adaptor protein in the acute phase of hypoferemia, we noticed that MyD88-deficient mice accumulate significantly more iron in their livers than wild-type mice in response to iron loading, and this independently of TLRs. Thus, in this third chapter of the present study, we studied the phenotype observed in MyD88-deficient mice. We found that HAMP expression in MyD88-deficient mice was lower than wild-type mice. Regarding this result, we explored the Bone Morphogenetic Proteins 6 (BMP6) signaling which is considered to be the fundamental pathway regulating HAMP levels in response to intracellular and extracellular iron concentrations and we found by western blot that Smad4 expression is significantly lower in MyD88-/- mice when compared to wild-type mice. We further show that MyD88 interacts with the mothers against decapentaplegic, Drosophila, homolog 4 (Smad4), a positive regulator of HAMP expression, and that this interaction is critical for HAMP induction through the Smad4 iron-sensing pathway. In conclusion, our study shows that HAMP expression in macrophages is regulated mainly through TLR2 and TLR4 receptors via the MyD88-dependent signaling pathway and that autocrine regulation of iron accumulation in macrophages by HAMP may affect the levels of proinflammatory cytokine production. Furthermore, our analysis shows that the development of hypoferremia during LPS response occur via a MyD88-dependent mechanism that is dissociated from peripheral cytokine production and hepatic HAMP induction. This work shows that MyD88 is required for Smad4 expression to guarantee an optimum response to BMP6 signaling, leading to adequate HAMP expression. Finally, the MyD88 adopter protein plays a crucial role in the regulation of HAMP expression by macrophages, the development of the hypoferremic response by LPS and the maintenance of iron homeostasis.

La candidose oro-pharyngée (COP) est l’infection opportuniste la plus répandue chez les patients infectés au VIH-1. Un modèle de COP chez la souris transgénique (Tg) exprimant une partie du génome du VIH-1 (CD4C/HIVMutA) est maintenant disponible. Grâce à ce modèle, il est possible d’étudier les perturbations quantitatives et fonctionnelles des macrophages exprimant les gènes nef, rev et env du VIH-1 dans le contexte d’une COP. Cette étude démontre que la présence du transgène n’influence pas le pourcentage des macrophages dans la muqueuse buccale et le petit intestin, malgré le fait que la charge buccale de C. albicans soit significativement plus élevée chez les souris Tg. Cependant, l’expression du transgène cause une diminution de la production de H2O2 par les macrophages, ainsi que l’augmentation de la production de la cytokine proinflammatoire IL-6 et de la chimiokine MCP-1. / Oro-pharyngeal candidiasis (OPC) is the most common opportunistic infection in HIV-1 infected patients. An OPC model using transgenic mice (CD4C/HIVMutA) expressing selected genes of the HIV-1 genome is now available. Using this model, it is now possible to study potential quantitative and functional disturbances in macrophages expressing the nef, rev and env genes of HIV-1 in the context of OPC. This study shows that transgene expression does not affect quantitative percentage values of macrophages in the oral mucosa and the small intestine, although burdens of C. albicans loads are increased in Tg mice. Transgene expression does induce diminished H2O2 production in macrophages, while increasing production of the proinflammatory cytokine IL-6 and the chemokine MCP-1.

Coronary artery disease (CAD) is caused by atherosclerosis, a chronic inflammatory response to modified lipoproteins. A key pathophysiological event is the lipid-induced transformation of macrophages into lipid-laden foam cells and their accumulation in atherosclerotic plaques. Heritable CAD risk is associated with common genetic variants at over 40 genomic loci; the underlying causal mechanisms remain largely unknown and could affect transcriptional regulation in foam cells. Epigenetic and gene expression changes were measured in primary human macrophages before and after exposure to atherogenic, oxidized low-density lipoprotein—with resultant foam cell formation. This unbiased approach involved open chromatin mapping with formaldehyde-assisted isolation of regulatory elements with enhancer and transcription factor mapping using chromatin immuno-precipitation. Foam cell formation was associated with changes in a subset of open chromatin and enhancer sites that were strongly correlated with expression of nearby genes. OxLDL-regulated enhancers were enriched for several transcription factors—including C/EBP-beta— that have no previously documented role in foam cell formation. OxLDL exposure up-regulated C/EBP-beta expression and increased C/EBP-beta binding across the genome, most prominently around genes involved in inflammatory response pathways. Variants at CAD-associated loci were enriched in the subset of oxLDLregulated open chromatin sites. These included rs72664324 in an oxLDL-induced super-enhancer at the PPAP2B locus. OxLDL increased C/EBP-beta binding at rs72664324. C/EBP-beta binding, enhancer activity and oxLDL-induced upregulation of PPAP2B were stronger with the protective A allele of rs72664324. The PPAP2B protein product LPP3 was expressed in foam cells in human atherosclerotic plaques and was upregulated by oxLDL exposure in macrophages, so increasing the degradation of pro-inflammatory mediators. I also found several other CAD risk candidate genes were regulated by oxLDL: Phosphatase and actin regulator 1 (PHACTR1) and macrophage inducible Ca²⁺ dependent C-type lectin (Mincle). This led us to find a novel expression-quantitative-trait locus for PHACTR1 in macrophages and define new glycolipid ligands for Mincle. Our results demonstrate a genetic mechanism contributing to CAD risk at the PPAP2B locus and highlight the value of integrating gene expression and epigenetic changes to study disease processes involving pathogenic environmental stimuli.

L’inflammation fait partie des processus réactionnels de défense dont dispose l’organisme en réponse aux agressions, assurant l’intégrité de l’hôte. En réponse au dommage tissulaire, plusieurs médiateurs inflammatoires interviennent dans le processus de l’inflammation. Lors de ces dommages, des signaux de dangers provenant de cellules endommagées sont relâchés dans l’environnement tissulaire, pouvant causer des dommages cellulaires et tissulaires. Les macrophages, tout comme d’autres cellules, peuvent être activés par ces signaux de danger, menant à la sécrétion de molécules telles que des cytokines et des chimiokines pouvant modifier le microenvironnement tissulaire. Les insultes au tissu sain peuvent entrainer la mort cellulaire telle que l’apoptose. Les molécules pouvant être relâchées lors de celle-ci contribuent au microenvironnement, notamment de par l’influence de celles-ci sur le macrophage. Parmi ces médiateurs, nous avons identifié le Milk Fat Globule-Epidermal growth factor 8 (MFG-E8), un acteur important dans la résolution de l’inflammation, comme étant relâché spécifiquement par les cellules apoptotiques. Nous avons émis l’hypothèse que le microenvironnement apoptotique tissulaire, via la relâche de MFG-E8, module le phénotype du macrophage, modifiant le microenvironnement, la réponse inflammatoire ainsi que le devenir de l’insulte tissulaire. Nos objectifs sont 1) de caractériser ce microenvironnement apoptotique tissulaire et la cinétique de relâche du MFG-E8 par les cellules apoptotiques, 2) d’en évaluer son rôle dans la modulation du phénotype du macrophage ainsi que 3) d’en étudier, in vivo, son influence sur l’environnement inflammatoire et le devenir tissulaire. Dans le premier article présenté, nous avons démontré que les cellules endothéliales apoptotiques relâchent le MFG-E8 de façon Caspase-3 dépendante. La stimulation des macrophages par l’environnement conditionné par les cellules endothéliales apoptotiques mène à l’adoption d’un profil macrophagien davantage anti-inflammatoire et moindrement pro-inflammatoire. Ce phénotype est réduit par l’inhibition de la Caspase-3 et il dépend de la présence de MFG-E8. De plus, le potentiel du MFG-E8 à la reprogrammation du macrophage pro-inflammatoire a été démontré via un modèle expérimental de péritonite. Ce changement phénotypique médié par MFG-E8 implique une signalisation STAT3. Ayant démontré que les cellules épithéliales apoptotiques, à l’instar des cellules endothéliales apoptotiques, relâchent elles aussi de façon apoptose-dépendante le MFG-E8, nous avons étudié plus exhaustivement un modèle in vivo riche en apoptose épithéliale, l’obstruction urétérale unilatérale. Dans ce deuxième article présenté, nous rapportons l’implication bénéfique de MFG-E8 dans ce modèle de pathologie rénale obstructive. Nous avons constaté que la présence ou l’administration de MFG-E8 réduit le dommage tissulaire et la fibrose. La protection conférée par MFG-E8 est médiée via la modulation de l’activation de l’inflammasome. De plus, nos résultats illustrent l’importance du phénotype anti-inflammatoire du macrophage médié par le MFG-E8 dans la régulation négative de l’activation de l’inflammasome rénal et du dommage tissulaire. Cette thèse présente la première description de la relâche Caspase-3-dépendante de MFG-E8 par les cellules apoptotiques. Elle démontre également l’importance du MFG-E8 dans le microenvironnement apoptotique inflammatoire dans l’atténuation du phénotype pro-inflammatoire du macrophage. De plus, nous avons démontré son rôle protecteur dans des modèles in vivo de transplantation aortique et de réparation tissulaire, de même que dans un modèle de maladie rénale chronique où nous avons montré que cette protection conférée par MFG-E8 est médiée par la régulation négative de l’inflammasome tissulaire. Nos résultats suggèrent ainsi que le MFG-E8 pourrait être considéré comme un interrupteur inflammatoire et ainsi comme une cible potentielle dans la modulation de maladies inflammatoires. / Inflammation is an important component of the « response to injury » process, allowing host integrity. In response to injury, released inflammatory mediators from damaged cells play a crucial role in the modification of the inflammatory microenvironment, which can lead to more cellular and tissue damages. Macrophages can be activated by those danger signals, leading to a spectrum of cytokines and chemokines secretion and modulating the tissular microenvironment. Tissue injuries can lead to cell death such as apoptosis. Mediators released during apoptosis contribute to the nature of the microenvironment, by their influence on macrophage amongst others. We have identified that Milk Fat Globule-Epidermal growth factor 8 (MFG-E8), an important actor in inflammation resolution, is specifically released by apoptotic cells. We hypothesized that tissular apoptotic microenvironment, through MFG-E8 release, modulates macrophage phenotype, resulting in the modification of microenvironment, inflammatory response and tissu injury outcome. Thus, our objectives were to 1) characterize this tissular apoptotic microenvironment by studying MFG-E8 release kinetic by apoptotic cells, to 2) evaluate its role in macrophage phenotype modulation and to 3) study, in vivo, its influence on inflammatory environment and tissu damage outcome. In the first study, we demonstrated that MFG-E8 is released by apoptotic endothelial cells in a caspase-3-dependent manner. When macrophages were exposed to conditioned media from apoptotic endothelial cells, they adopt a high anti-inflammatory, low pro-inflammatory cytokine/chemokine secreting phenotype that is lost if apoptosis is inhibited or if MFG-E8 is absent from the media. Furthermore, MFG-E8 potential to anti-inflammatory macrophage reprogramming has been demonstrated in the experimental peritonitis model. This MFG-E8-mediated reprogramming of macrophages occurs through increased phosphorylation of STAT-3. As apoptotic endothelial cells, apoptotic epithelial cells also release MFG-E8 in an apoptotic-dependent manner. Thus, we investiguated more exhaustively an in vivo epithelial apoptosis rich model, the unilateral ureteral obstruction. In this second study, we report the positive impact of MFG-E8 in this renal obstructive model. MFG-E8 administration reduced kidney damage and fibrosis compared to the control, whereas its absence in MFG-E8 KO mice was associated with more severe disease. Moreover, we demonstrated that the protective role of MFG-E8 is mediated through inflammasome activation modulation in the kidney. Furthermore, our results showed the importance of the anti-inflammatory macrophage phenotype that results in decreased inflammasome activation, preventing severe tissue damage. This thesis presents the first description of apoptosis-dependent release of MFG-E8 by apoptotic cells. It also demonstrate the importance of MFG-E8 in inflammatory apoptotic microenvironment, leading to pro-inflammatory macrophage phenotype attenuation. Moreover, we demonstrated MFG-E8 protective role in an aortic transplantation and a tissue repair models, as well as in a chronic kidney disease model where we showed that this MFG-E8 confered protection is mediated by negative regulation of tissular inflammasome activation. These data provide valuable insight for identifying MFG-E8 as a novel target in the modulation of inflammatory diseases and could be considerate as an inflammatory switch.

Depuis les 15 dernières années, de nombreuses études ont mis en évidence le rôle majeur de l’architecture nucléaire dans la régulation de l’expression des gènes et ceci dans une grande diversité de processus biologiques. Bien que la réponse immunitaire soit un de ces processus, peu de données existent sur l’organisation spatiale du génome dans les cellules immunitaires et son impact sur la régulation des gènes dans le contexte d’une réponse à l’infection bactérienne. En utilisant le porc comme organisme modèle, nous avons concentré notre étude sur les macrophages dérivés de monocytes, premières lignes de défense contre les pathogènes. Les cellules immunitaires étant les cibles des mycotoxines, nous nous sommes également intéressés aux effets de la toxine T-2 sur les macrophages et leur réponse induite par les récepteurs TLR. Un effet cytotoxique de la T-2 à une dose de 10 nM, ainsi que des effets inhibiteurs sur certaines réponses liées aux récepteurs TLR ont été mis en évidence. Nous avons ensuite examiné si les changements dans l'expression des gènes dus à l'activation impliquent un repositionnement dans l'espace nucléaire. Une analyse du transcriptome a permis d’identifier les gènes différentiellement exprimés dans les macrophages activés par le mélange LPS-IFNγ et de mettre en évidence des réseaux de gènes impliqués lors de l’activation. Les 4 gènes les plus sur-exprimés (IL1β, IL8, CXCL10 et TNFα) et les 4 gènes les plus sous-exprimés (VIM, LGALS3, TUBA3 et IGF2) ont été sélectionnés pour analyser leur comportement dans l'espace nucléaire au cours de l’activation des macrophages en utilisant la technique FISH 3D. Parmi les 4 gènes sur-exprimés, 3 présentent des modifications de leur position durant le processus d'activation alors que les 4 gènes sous-exprimés ne montent pas de variation de leur position. L'analyse de la position des gènes par rapport à leurs territoires chromosomiques (TC) a été étendue à un second type de cellules immunitaires : les neutrophiles. Des résultats similaires ont été obtenus. Les analyses ont été ensuite complétées par l'étude des 4 gènes sur-exprimés dans un type cellulaire indépendant de la réponse immunitaire (fibroblastes). Nos données suggèrent que les relocalisations dans l'espace nucléaire des gènes différentiellement exprimés dans les cellules immunitaires activées sont gène spécifique, type cellulaire spécifique et concernent essentiellement ceux qui sont sur-exprimés. / For the past 15 years, numerous studies have highlighted the role of nuclear architecture in regulating gene expression in a variety of biological processes. Although the immune response is one of these processes, few data exist on the spatial organization of the genome in immune cells and its impact on gene regulation in the context of a response to bacterial infection. Using pigs as a model organism, we focused our study on monocytederived macrophages, the first lines of defence against pathogens. As immune cells are the targets of mycotoxins, we also studied the effects of T-2 toxin on macrophages and on their responses induced by TLRs. A cytotoxic effect of T-2 at a dose of 10 nM, and an inhibitory effect on some responses related to TLRs have been demonstrated. We then examined whether changes in gene expression due to activation involve a repositioning within the nuclear space. A transcriptome analysis allowed us to identify differentially expressed genes in macrophages activated by LPS-IFNγ and to analyze gene networks involved during activation. The top 4 up-regulated genes (IL1 beta, IL-8, CXCL10 and TNF) and the top 4 down-regulated ones (VIM LGALS3, TUBA3 and IGF2) have been selected to analyze their behaviour in nuclear space during macrophages activation using 3D FISH technique. Among the 4 up-regulated genes, 3 show changes in their position during the activation process while the 4 down-regulated ones did not reposition. The analysis of gene behaviours towards their chromosome territories (CT) was extended to neutrophils and similar results were obtained. The analyses were then completed by the study of the 4 up-regulated genes in a non immune cell type (fibroblast). Our data suggest that relocation in the nuclear space of genes differentially expressed in activated immune cells is gene and cell type specific and mostly concerns those that are up-regulated.

Mycobacterium tuberculosis (Mtb) is the pathogen causing tuberculosis (TB), a disease most often affecting the lung. 1.5 million people die annually due to TB, mainly in low-income countries. Usually considered a disease of the poor, also developed nations recently put TB back on their agenda, fueled by the HIV epidemic and the global emergence of drug-resistant Mtb strains. HIV-coinfection is a predisposing factor for TB, and infection with multi-drug resistant and extremely drug resistant strains significantly impedes and lengthens antibiotic treatment, and increases fatality. Mtb is transmitted from a sick individual via coughing, and resident macrophages are the first cells to encounter the bacterium upon inhalation. These cells phagocytose intruders and subject them to a range of destructive mechanisms, aiming at killing pathogens and protecting the host. Mtb, however, has evolved to cope with host pressures, and has developed mechanisms to submerge macrophage defenses. Among these, inhibition of phagosomal maturation and adaptation to the intracellular environment are important features. Mtb profoundly alters its phenotype inside host cells, characterized by altered metabolism and slower growth. These adaptations contribute to the ability of Mtb to remain dormant inside a host during latent TB infection, a state that can last for decades. According to recent estimates, one third of the world’s population is latently infected with Mtb, which represents a huge reservoir for active TB disease. Mtb is also intrinsically tolerant to many antibiotics, and adaptation to host pressures enhances tolerance to first-line TB drugs. Therefore, TB antibiotic therapy takes 6 to 9 months, and current treatment regimens involve a combination of several antibiotics. Patient noncompliance due to therapeutic side effects as well as insufficient penetration of drugs into TB lesions are reasons for treatment failure and can lead to the rise of drug-resistant populations. In view of the global spread of drug-resistant strains, new antibiotics and treatment strategies are urgently needed. In this thesis, we studied the interplay of the primary host cell of Mtb, human macrophages, and different Mtb phenotypes. A low-burden infection resulted in restriction of Mtb replication via phagolysosomal effectors and the maintenance of an inactive Mtb phenotype reminiscent of dormant bacteria. Macrophages remained viable for up to 14 days, and profiling of secreted cytokines mirrored a silent infection. On the contrary, higher bacterial numbers inside macrophages could not be controlled by phagolysosomal functions, and intracellular Mtb shifted their phenotype towards active replication. Although slowed mycobacterial replication is believed to render Mtb tolerant to antibiotics, we did not observe such an effect. Mtb-induced macrophage cell death is dependent on ESAT6, a small mycobacterial virulence factor involved in host cell necrosis and the spread of the pathogen. Although well-studied, the fate of ESAT6 inside infected macrophages has been enigmatic. Cultivation of Mtb is commonly carried out in broth containing detergent to avoid aggregation of bacilli due to their waxy cell wall. Altering cultivation conditions revealed the presence of a mycobacterial capsule, and ESAT6 situated on the mycobacterial surface. Infection of macrophages with this encapsulated Mtb phenotype resulted in rapid ESAT6-dependent host cell death, and ESAT6 staining was lost as bacilli were ingested by macrophages. These observations could reflect the earlier reported integration of ESAT6 into membranes followed by membrane rupture and host cell death. In conclusion, the work presented in this thesis shows that the phenotype of Mtb has a significant impact on the struggle between the pathogen and human macrophages. Taking the bacterial phenotype into account can lead to the development of drugs active against altered bacterial populations that are not targeted by conventional antibiotics. Furthermore, deeper knowledge on Mtb virulence factors can inform the development of virulence blockers, a new class of antibiotics with great therapeutic potential.

A leishmaniose é um termo global para doenças causadas por parasitos do gênero Leishmania, sendo a Leishmaniose Visceral (LV) a forma mais grave da doença. No Brasil é causada pelo parasita Leishmania (Leishmania) infantum chagasi. Para garantir a sua sobrevivência, alguns parasitas são capazes de manipular respostas de defesa das células do sistema imune. Recentes estudos demonstraram a participação da proteína imunomodulatória CD200 durante o processo de infecção de L. (L.) amazonenses. O presente estudo teve como objetivo investigar se os parasitos L. (L.) infantum chagasi são capazes de induzir a expressão da proteína CD200 durante o processo infeccioso. Em ensaios de infecção ex vivo, não foi observado proliferação de parasitas intracelulares. Apesar disso, L. (L.) infantum chagasi foi capaz de induzir a expressão do gene CD200. De maneira interessante, diferente de infecções por L. (L.) amazonenses, a indução de CD200 nessas células foi observada em tempos mais tardios de infecção. Ensaios de imunoprecipitação e Western blot indicaram a síntese da proteína, que atingiu os seus maiores níveis a 120 horas pós-infecção. A presença de CD200 sugere o envolvimento dessa molécula em tempos mais tardios de infecção por L. (L.) infantum chagasi. / Leishmaniasis is a global term for diseases caused by parasites of the genus Leishmania, and Visceral Leishmaniasis (VL) are the most severe form of the disease. In Brazil is caused by the parasite Leishmania (Leishmania) infantum chagasi. To ensure their survival, some parasites can handle defensive responses of the cells of the immune system. Recent studies have demonstrated the participation of immunomodulatory protein CD200 during the infection process of L. (L.) amazonenses. This study aimed to investigate whether the parasites L. (L.) infantum chagasi are capable of inducing the expression of CD200 protein during the infectious process. In trials of ex vivo infection, there was no proliferation of intracellular parasites. Nevertheless, L. (L.) infantum chagasi was able to induce the expression of CD200 gene. Interestingly, unlike infection by L. (L.) amazonenses, CD200 induction of these cells was observed at later times in infection. Immunoprecipitation assays and Western blot indicated protein synthesis, which reached their highest levels at 120 hours post-infection. The presence of CD200 suggests the involvement of this molecule at later times of infection with L. (L.) infantum chagasi.

O diabetes mellitus tipo I (DMI) é uma doença crônica autoimune caracterizada por hiperglicemia devido à destruição das células beta pancreáticas produtoras de insulina. Ao final de 30 dias da indução do diabetes por estreptozotocina, os macrófagos peritoneais residentes dos animais diabéticos apresentaram aumento de RNAm de citocinas e quimiocinas inflamatórias, secreção de óxido nítrico, expressão de NLRP3, iNOS e PARP1 e da atividade da via glicolítica. Perfil pró-inflamatório também foi observado em macrófagos peritoneais de animais NOD (non-obese diabetic). Camundongos diabéticos deficientes em NLRP3 (NLRP3 KO) apresentaram diminuição na expressão de iNOS, PARP1 e na produção de NO em relação aos macrófagos dos animais diabéticos selvagens. O estado diabético tipo I influenciou o perfil dos macrófagos peritoneais residentes, causando aumento na produção de NO, via NLRP3-PARP1-iNOS, expressão de citocinas pró-inflamatórias, receptores de quimiocinas e da atividade glicolítica. O tratamento com DHA (ômega-3) ex-vivo reverteu este perfil e atenuou o quadro pró-inflamatório por diminuição da produção de NO e da expressão de citocinas pró-inflamatórias. / Type I diabetes mellitus (DMI) is a chronic autoimmune disease characterized by hyperglycemia due to the destruction of insulin-producing pancreatic beta cells. At the end of 30 days after type I diabetes induced by streptozotocin, macrophages from diabetic animals had increased expressions of inflammatory cytokines and chemokines, secretion of nitric oxide, expression of NLRP3, iNOS and PARP1, and glycolytic activity compared to the cells from control animals. Proinflammatory features was also observed in peritoneal macrophages of NOD (non-obese diabetic) animals. Macrophages from NLRP3 deficient diabetic mice (NLRP3 KO) had decreased expression of iNOS, PARP1 and of NO production when compared to cells from wild type animals. The type I diabetic state led to a proinflammatory feature in resident peritoneal macrophages by increasing NO production, via the NLRP3-PARP1-iNOS pathway, expressions of proinflammatory cytokines, chemokine receptors and glycolytic activity. In contrast, ex-vivo treatment with DHA (omega-3) reversed this profile and attenuated the proinflammatory state by reducing NO production and expression of proinflammatory cytokines.

O envelhecimento é marcado por inúmeras alterações fisiológicas, dentre as quais encontramos um aumento da gordura corporal e alterações na resposta do sistema imunológico. Muito se sabe sobre a intrínseca ligação entre o aumento de gordura e as doenças de risco e fica a questão à cerca de sua influência sobre as respostas do sistema imunológico, já que estes dois fatores encontram-se alterados no envelhecimento. Portanto, o propósito deste estudo foi investigar a interação entre a quantidade de gordura corporal e as células do sistema imunológico de ratos envelhecidos. Para isso, num primeiro estudo, foram utilizados ratos ADULTOS e ENVELHECIDOS para a caracterização das alterações encontradas no processo de envelhecimento. Numa segunda etapa, os animais ENVELHECIDOS foram submetidos a dois protocolos de emagrecimento, a restrição calórica a 50%(RC) e o exercício aeróbio (EX) (natação), durante o período de quatro a seis semanas. Assim, foi possível avaliar alguns parâmetros do metabolismo de macrófagos e linfócitos em ratos envelhecidos com diferentes quantidades de gordura corporal. No primeiro estudo, os resultados comprovaram o aumento da gordura bem como algumas alterações no sistema imunológico de ratos envelhecidos, principalmente na capacidade funcional de macrófagos. Quanto ao segundo estudo, os resultados demonstram que ambos os protocolos foram eficientes em diminuir o peso corporal, bem como a gordura, sendo que para a RC os valores alcançados foram mais evidentes. Com relação ao sistema imunológico houve um aumento da resposta fagocitária e de produção de H2O2 por macrófagos e uma alteração da capacidade proliferativa de linfócitos, em ambos os protocolos. / Ageing is marked by several kinds of physiological changes, among then we find an increase of fat mass and a decline in several aspects of the immune system. It is well understood the intrinsical connexion between the increase in body fat and the risk of related diseases and the one question that remains is about the influence over the immune system response, since these two factors are altered on the ageing process. The purpose of this study was to investigate the relationship among fat content and immune cells of the aging rats. For this, in one first study, we used ADULTS and AGEING rats to determine the changes found in the ageing process. In the second time, the AGEING rats were submitted to two protocols for weight loss (slimming), 50% of caloric restriction (CR) and aerobic exercise (swimming) (EX), for four or six weeks. In this way, we can study some parameters of macrophages and lymphocytes metabolism in ageing rats with different body fat content. In the first study, the results confirmed the fat increase as well as some changes in the immune system of the ageing rats, especially in the macrophages functional capabilities. In the second study, the results showed that both protocols decreased body fat and weight, with the best results happening with CR protocol. The immune system had an increase on the phagocytic response and H2O2 production for macrophages and alterations of the proliferative capacities of the lymphocytes, in both protocols.